Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Xeriant (XERI) Research & Development (2018 - 2020)

Xeriant (XERI) has disclosed Research & Development for 3 consecutive years, with $37.0 as the latest value for Q2 2020.

  • Quarterly Research & Development fell 98.94% to $37.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $6376.0 through Jun 2020, changed N/A year-over-year, with the annual reading at $69274.0 for FY2025, 64.73% down from the prior year.
  • Research & Development hit $37.0 in Q2 2020 for Xeriant, down from $6339.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6339.0 in Q3 2019 to a low of $37.0 in Q2 2020.
  • Historically, Research & Development has averaged $2952.0 across 3 years, with a median of $2900.0 in 2019.
  • Biggest YoY gain for Research & Development was 98.94% in 2020; the steepest drop was 98.94% in 2020.
  • Year by year, Research & Development stood at $1982.0 in 2018, then skyrocketed by 219.83% to $6339.0 in 2019, then plummeted by 99.42% to $37.0 in 2020.
  • Business Quant data shows Research & Development for XERI at $37.0 in Q2 2020, $6339.0 in Q3 2019, and $3502.0 in Q2 2019.